← Back
$COLL All transactions

COLLEGIUM PHARMACEUTICAL, INC

▼ SELL 10b5-1 Plan

$ Value

$315K

Shares

6,475

Price

$49

Filed

Dec 10

Insider

Name

Dreyer Scott

Title

EVP & Chief Commercial Officer

CIK

0001746251

Roles

Officer

Transaction Details

Transaction Date

2025-12-08

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

103,613

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2025. | The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.212 to $48.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. | The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.215 to $49.08, inclusive. | The option is fully vested and exercisable.

Filing Info

Accession No.

0001746251-25-000004

Form Type

4

Issuer CIK

0001267565

Dreyer Scott's History

Date Ticker Type Value
2026-02-10 COLL A $0
2026-02-10 COLL A $0
2026-02-10 COLL F $466K
2026-02-10 COLL F $1.0M
2025-12-08 COLL M $280K
2025-12-08 COLL $533K
2025-12-08 COLL $315K
2025-12-08 COLL M $0
2025-08-18 COLL M $350K
2025-08-18 COLL $626K

Other Insiders at COLL (90d)

Insider Bought Sold Last
Karnani Vikram
President and CEO
2026-02-10
Dreyer Scott
EVP & Chief Commercial Officer
2026-02-10
Smith Thomas B
EVP and Chief Medical Officer
2026-02-10
Tupper Colleen
EVP & Chief Financial Officer
2026-02-10
Dieter David
EVP & General Counsel
2026-03-17